RBM42
RNA-binding protein 42
Also known as: MGC10433, RBM42_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BTD8
- Gene
- RBM42
- Ensembl
- ENSG00000126254
- Chromosome
- 19
- Canonical length
- 480 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables RNA binding activity. Predicted to be involved in mRNA splicing, via spliceosome. Predicted to act upstream of or within negative regulation of mRNA splicing, via spliceosome. Part of U4/U6 x U5 tri-snRNP complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
480 residues, UniProt reviewed canonical sequence.
>Q9BTD8|RBM42
1 MAGAGPAPGL PGAGGPVVPG PGAGIPGKSG EERLKEMEAE MALFEQEVLG APVPGIPTAV
61 PAVPTVPTVP TVEAMQVPAA PVIRPIIATN TYQQVQQTLE ARAAAAATVV PPMVGGPPFV
121 GPVGFGPGDR SHLDSPEARE AMFLRRAAVA PQRAPILRPA FVPHVLQRAD SALSSAAAGP
181 RPMALRPPHQ ALVGPPLPGP PGPPMMLPPM ARAPGPPLGS MAALRPPLEE PAAPRELGLG
241 LGLGLKEKEE AVVAAAAGLE EASAAVAVGA GGAPAGPAVI GPSLPLALAM PLPEPEPLPL
301 PLEVVRGLLP PLRIPELLSL RPRPRPPRPE PPPGLMALEV PEPLGEDKKK GKPEKLKRCI
361 RTAAGSSWED PSLLEWDADD FRIFCGDLGN EVNDDILARA FSRFPSFLKA KVIRDKRTGK
421 TKGYGFVSFK DPSDYVRAMR EMNGKYVGSR PIKLRKSMWK DRNLDVVRKK QKEKKKLGLRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBM42 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 73 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 73 nTPM
- blood vessel: 66 nTPM
- skin: 64 nTPM
- endometrium: 61 nTPM
- heart muscle: 58 nTPM
- colon: 57 nTPM
Single-cell type
- syncytiotrophoblasts: 517 nCPM
- cytotrophoblasts: 234 nCPM
- oocytes: 193 nCPM
- migrating cytotrophoblasts: 181 nCPM
- esophageal apical cells: 156 nCPM
- extravillous trophoblasts: 122 nCPM
Immune cell
- eosinophil: 125 nTPM
- basophil: 99 nTPM
- intermediate monocyte: 96 nTPM
- non-classical monocyte: 95 nTPM
- myeloid DC: 95 nTPM
- plasmacytoid DC: 88 nTPM
Brain region
- medulla oblongata: 65 nTPM
- white matter: 61 nTPM
- cerebellum: 60 nTPM
- basal ganglia: 55 nTPM
- pons: 53 nTPM
- thalamus: 52 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.75
- gnomAD missense Z
- 2.39
- DepMap mean gene effect
- -0.57
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- RNA recognition motif
- RBM42, RNA recognition motif
- RNA-binding protein 42/Polyadenylate-binding protein RBP45/47-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RBM42 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBM42 as an antibody target. Whether an autoantibody or antibody against RBM42 could matter depends on whether native RBM42 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBM42 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBM42 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...